1.96
2.97%
-0.06
After Hours:
2.03
0.07
+3.57%
Alaunos Therapeutics Inc Stock (TCRT) Forecast
The Alaunos Therapeutics Inc (TCRT) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $3.122, representing a +59.28% increase from the current price of $1.96. The highest analyst price target is $4.4962, and the lowest is $1.7478.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month TCRT Price Target
Average 2.7339
(+39.48% Upside)
Is Alaunos Therapeutics Inc (TCRT) A Buy Now?
Oscillators
Name | Value | Action |
---|---|---|
RSI(14) | 44.39 | Neutral |
STOCH(9,6) | 36.06 | Neutral |
STOCHRSI(14) | 58.79 | Neutral |
MACD(12,26) | -0.0956 | Sell |
ADX(14) | 17.76 | Neutral |
William %R | -77.55 | Neutral |
CCI(14) | -36.74 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
Period | Simple | Exponential |
---|---|---|
MA10 |
2.0018
Sell
|
2.0267
Sell
|
MA20 |
2.2077
Sell
|
2.1094
Sell
|
MA50 |
2.1829
Sell
|
2.3261
Sell
|
MA100 |
2.4448
Sell
|
3.4019
Sell
|
MA200 |
6.9052
Sell
|
6.3756
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, TCRT could be considered a Strong Sell, with 17 technical analysis indicators signaling 0 Buy signals, 11 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on TCRT, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 44.39 indicates that TCRT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 36.06 indicates that TCRT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 58.79 indicates that TCRT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 17.76 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -36.74 indicates that TCRT is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term TCRT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Alaunos Therapeutics Inc financial reports and earnings history, Alaunos Therapeutics Inc (TCRT) stock could reach $3.4792 by 2030, $3.9612 by 2040 and $7.774 by 2050. See the projected annual prices until 2050 of the Alaunos Therapeutics Inc stock below:
- Alaunos Therapeutics Inc (TCRT) is expected to reach an average price of $3.6425 in 2035, with a high prediction of $3.8225 and a low estimate of $2.8114. This indicates an $85.84% rise from the last recorded price of $1.96.
- Alaunos Therapeutics Inc (TCRT) stock is projected to chart a bullish course in 2040, with an average price target of $3.6874, representing an $88.13% surge from its current level. The forecast ranges from a conservative $3.5613 to a sky-high $3.9612.
- Our analysts predict Alaunos Therapeutics Inc (TCRT) to jump 136.63% by 2045, soaring from $4.5616 to an average price of $4.6379, potentially reaching $4.7863. While $4.5616 is the low estimate, the potential upside is significant.
- Alaunos Therapeutics Inc (TCRT) stock is expected to climb by 2050, reaching an average of $5.7092, a $191.29% jump from its current level. However, a wide range of estimates exists, with high and low targets of $7.774 and $5.5201, respectively, highlighting the market's uncertainty.
Alaunos Therapeutics Inc Stock (TCRT) Year by Year Forecast
Alaunos Therapeutics Inc Stock (TCRT) Price Forecast for 2025
Alaunos Therapeutics Inc Stock (TCRT) is expected to reach an average price of $2.7339 in 2025, with a high prediction of $4.4962 and a low estimate of $0.9716. This indicates an +39.48% rise from the last recorded price of $1.96.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2025 | $2.211 | $1.7478 | $4.4962 | +12.80% |
February, 2025 | $1.6874 | $1.5374 | $2.3426 | -13.91% |
March, 2025 | $1.477 | $1.3838 | $1.7122 | -24.64% |
April, 2025 | $1.1011 | $1.1011 | $1.5054 | -43.82% |
May, 2025 | $1.3155 | $1.015 | $1.3382 | -32.88% |
June, 2025 | $1.2181 | $1.1716 | $1.3795 | -37.85% |
July, 2025 | $1.0996 | $1.0637 | $1.2457 | -43.90% |
August, 2025 | $1.1691 | $0.9893 | $1.2391 | -40.35% |
September, 2025 | $1.1155 | $1.0245 | $1.1807 | -43.09% |
October, 2025 | $1.0524 | $1.0256 | $1.2483 | -46.30% |
November, 2025 | $1.011 | $1.0074 | $1.09 | -48.42% |
December, 2025 | $1.012 | $0.9716 | $1.0832 | -48.37% |
Alaunos Therapeutics Inc Stock (TCRT) Price Forecast for 2026
The predicted value for Alaunos Therapeutics Inc (TCRT) in 2026 is set at an average of $1.936. Estimates vary from a peak of $3.2257 to a trough of $0.6462, indicating an -1.23% surge from the present price of $1.96.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2026 | $0.6978 | $0.6951 | $1.0562 | -64.40% |
February, 2026 | $0.7082 | $0.696 | $0.7939 | -63.87% |
March, 2026 | $0.6984 | $0.6904 | $0.739 | -64.37% |
April, 2026 | $0.6716 | $0.6593 | $0.7094 | -65.74% |
May, 2026 | $0.6679 | $0.6462 | $0.7056 | -65.92% |
June, 2026 | $0.6576 | $0.6505 | $0.6749 | -66.45% |
July, 2026 | $0.7918 | $0.659 | $0.8351 | -59.60% |
August, 2026 | $2.3325 | $0.7677 | $3.1009 | +19.01% |
September, 2026 | $2.3406 | $1.9641 | $3.2257 | +19.42% |
October, 2026 | $2.247 | $2.187 | $2.6622 | +14.64% |
November, 2026 | $1.9144 | $1.6202 | $2.2086 | -2.33% |
December, 2026 | $1.6608 | $1.6397 | $1.9328 | -15.26% |
Alaunos Therapeutics Inc Stock (TCRT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Alaunos Therapeutics Inc (TCRT) is $3.1447, with a high forecast of $4.9823 and a low forecast of $1.307. This indicates an +60.44% increase from the last price of $1.96.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2027 | $1.5381 | $1.4843 | $1.7639 | -21.53% |
February, 2027 | $1.3905 | $1.3086 | $1.5722 | -29.06% |
March, 2027 | $1.4724 | $1.307 | $1.6908 | -24.88% |
April, 2027 | $1.7929 | $1.381 | $1.9142 | -8.53% |
May, 2027 | $2.2802 | $1.7006 | $2.417 | +16.34% |
June, 2027 | $2.6063 | $1.9499 | $2.8563 | +32.97% |
July, 2027 | $3.8691 | $2.5827 | $4.0841 | +97.40% |
August, 2027 | $2.7019 | $2.2355 | $4.9823 | +37.85% |
September, 2027 | $2.148 | $2.0348 | $2.8351 | +9.59% |
October, 2027 | $1.9369 | $1.8876 | $2.2144 | -1.18% |
November, 2027 | $1.613 | $1.613 | $1.9539 | -17.71% |
December, 2027 | $1.7861 | $1.5301 | $1.8993 | -8.87% |
Alaunos Therapeutics Inc Stock (TCRT) Price Forecast for 2028
In 2028, Alaunos Therapeutics Inc (TCRT) is projected to reach an average price of $1.5346, with a high projection of $1.823 and a low estimate of $1.2462. This indicates an -21.70% fall from the last price of $1.96.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2028 | $1.7067 | $1.682 | $1.823 | -12.92% |
February, 2028 | $1.6323 | $1.5964 | $1.734 | -16.72% |
March, 2028 | $1.6814 | $1.5268 | $1.7782 | -14.21% |
April, 2028 | $1.6801 | $1.57 | $1.7043 | -14.28% |
May, 2028 | $1.6107 | $1.5792 | $1.7987 | -17.82% |
June, 2028 | $1.6331 | $1.5331 | $1.6499 | -16.68% |
July, 2028 | $1.58 | $1.5676 | $1.6463 | -19.39% |
August, 2028 | $1.2918 | $1.2695 | $1.6274 | -34.09% |
September, 2028 | $1.291 | $1.276 | $1.3049 | -34.14% |
October, 2028 | $1.2876 | $1.2777 | $1.3231 | -34.31% |
November, 2028 | $1.2886 | $1.2529 | $1.3024 | -34.25% |
December, 2028 | $1.2756 | $1.2462 | $1.2904 | -34.92% |
Alaunos Therapeutics Inc Stock (TCRT) Price Forecast for 2029
The 2029 price forecast for Alaunos Therapeutics Inc Stock (TCRT) is $2.5542 on average, with a high prediction of $3.8515 and a low estimate of $1.257. This represents an +30.32% increase from the previous price of $1.96.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2029 | $1.3536 | $1.257 | $1.4082 | -30.94% |
February, 2029 | $1.404 | $1.3408 | $1.4512 | -28.36% |
March, 2029 | $3.1783 | $2.5883 | $3.7219 | +62.16% |
April, 2029 | $2.9711 | $2.7711 | $3.8515 | +51.59% |
May, 2029 | $2.3972 | $2.3772 | $3.2943 | +22.30% |
June, 2029 | $2.15 | $2.0801 | $2.6836 | +9.69% |
July, 2029 | $2.0973 | $2.0729 | $2.3693 | +7.00% |
August, 2029 | $1.9712 | $1.9239 | $2.202 | +0.57% |
September, 2029 | $1.884 | $1.7579 | $2.0081 | -3.88% |
October, 2029 | $1.8944 | $1.8074 | $2.1449 | -3.34% |
November, 2029 | $2.3339 | $1.8415 | $2.4359 | +19.08% |
December, 2029 | $2.7351 | $2.2507 | $2.8942 | +39.55% |
Alaunos Therapeutics Inc Stock (TCRT) Price Forecast for 2030
Alaunos Therapeutics Inc Stock (TCRT) is expected to reach an average price of $3.7568 in 2030, with a high forecast of $5.4685 and a low forecast of $2.0451. This signifies an +91.67% surge from the last price of $1.96.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2030 | $3.2392 | $2.4248 | $3.4792 | +65.27% |
February, 2030 | $5.1485 | $3.064 | $5.4685 | +162.68% |
March, 2030 | $2.9377 | $2.7233 | $5.2233 | +49.88% |
April, 2030 | $2.647 | $2.5322 | $2.9925 | +35.05% |
May, 2030 | $2.159 | $2.136 | $2.7166 | +10.16% |
June, 2030 | $2.128 | $2.0719 | $2.2507 | +8.57% |
July, 2030 | $2.2993 | $2.0451 | $2.4192 | +17.31% |
August, 2030 | $2.2195 | $2.1886 | $2.3477 | +13.24% |
September, 2030 | $2.1133 | $2.0929 | $2.2529 | +7.82% |
October, 2030 | $2.1969 | $2.0643 | $2.3173 | +12.09% |
November, 2030 | $2.2162 | $2.1156 | $2.2662 | +13.07% |
December, 2030 | $2.1658 | $2.1327 | $2.349 | +10.50% |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):